UK MHRA alerts companies to BSI standard on use of Braille
This article was originally published in SRA
Executive Summary
The UK Medicines and Healthcare Products Regulatory Agency has issued an alert informing pharmaceutical companies about a BSI standard that provides guidance on the use of Braille on the packaging of medicinal products1,2. Companies demonstrating compliance to the standard (BS EN 15823:2010 Packaging: Braille on packaging for medicinal products), the agency says, will be regarded as meeting the regulatory provisions of the EU medicines legislation (Directive 2001/83/EC, as amended).